跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
贺可唯 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Human Follitropin delta Injection
Approved
生物制品
Human Follitropin delta Injection
Ferring Pharmaceuticals A/S
🇨🇳 National Medical Products Administration
Approval Date
Apr 30, 2024
Approval ID
8ZleToQFi27
Company
Ferring Pharmaceuticals A/S
Type
生物制品
Approval Details
Approval Id
8ZleToQFi27
Approval Number
国药准字SJ20240015
Generic Name
人促卵泡激素δ注射液
Generic Name En
Human Follitropin delta Injection
Trade Name
贺可唯
Drug Type
生物制品
Dosage Form
注射剂
Strength
1.08mL: 36μg
Reg Date
2024-04-30
Expired Date
2029-04-29
Company Name
Ferring Pharmaceuticals A/S
Production Company Name
Vetter Pharma-Fertigung GmbH & Co. KG
Company Detail Path
/organization/ferring-pharmaceuticals-a-s
Production Company Detail Path
/organization/vetter-pharma-fertigung-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 30, 2024
Approval ID
8ZleToQFi27
Type
生物制品
Back to NMPA Approvals